IQVIA is investing in the SaaS-based, OCT platform to modernize and digitize the clinical development process and provide better outcomes for both sponsor and patient. OCT moves beyond simply automation of workflows to true orchestration, producing an uninterrupted flow of data-driven evidence that quickly closes the gap between data collection and clinical decision-making.
At IQVIA, we understand that where a life science organization places its data matters, so we have developed four applications focused on the digital transformation of trials while ensuring clinician and patient engagement throughout the clinical development process
Identify the best performing sites for your trial in less time with new machine learning and predictive modeling methods.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.
Bring trials directly to patients to decrease costs, increase quality and improve access.